Rumalon®
K.O.Romparm Company S.R.L.
1882 Items
2019-09-19
- done All payments are SSL encrypted
- done Full Refund if you haven't received your order
- done International shipping to the USA, UK and Europe
Clinical Pharmacology
Combined preparation of animal origin, contains a glycosaminoglycan-peptide complex. The action of the drug is due to the combined action of its active components. Normalizes metabolism in cartilaginous hyaline tissue: enhances the biosynthesis of sulfated mucopolysaccharides and collagen, stimulates the regeneration of articular cartilage, reduces enzyme activity and inhibits catabolic processes in cartilage tissue.
No customer reviews for the moment.
The drug is administered deeply intramuscularly: on the first day - 0.3 ml, on the second day - 0.5 ml, and then 3 times a week, 1 ml for 5-6 weeks. A second course of treatment - after consulting a doctor according to the same scheme.
Contraindications
Contraindications: hypersensitivity to the components of the drug, rheumatoid arthritis, age up to 18 years, pregnancy, breastfeeding period, use in women of reproductive age who do not follow reliable methods of contraception.- Brand name: Rumalon injection
- Active ingredient: Glycosaminoglycan Peptide Complex
- Manufacturer: K.O.Romparm Company S.R.L.
- Country of Origin: Romania
Studies and clinical trials of Rumalon (Click to expand)
- Improving Stone Clearance After Extracorporeal Shock Wave Lithotripsy in Urolithiasis Patients by a Special Terpene Combination (Rowatinex®): Results of a Placebo-Controlled, Randomized Trial
- S197 EVALUATION OF THE EFFICIENCY OF TAMSULOSIN AND ROWATINEX IN PATIENTS WITH DISTAL URETERAL STONES: A PROSPECTIVE, RANDOMIZED, CONTROLLED STUDY
- S222 The efficacy of Rowatinex and Tamsulosin in patients with selected ureteral stones: One a controlled study
- E81 The efficacy of Rowatinex and Tamsulosin in selected patients with ureteral stones: A controlled study
- A Special Terpene Combination (Rowatinex®) Improves Stone Clearance after Extracorporeal Shockwave Lithotripsy in Urolithiasis Patients: Results of a Placebo-Controlled Randomised Controlled Trial
- The antibacterial activity of Rowatinex
- MP33-05 IN VITRO STUDY ON URETERAL SMOOTH MUSCLE CONTRACTILITY WITH TAMSULOSIN, NIFEDIPINE, AND TERPENE MIXTURE (ROWATINEX¢Ç)
- MP34-18 IN VITRO STUDY, THE ROLE OF RHO-KINASE IN URETERAL SMOOTH MUSCLE RELAXATION WITH TAMSULOSIN AND TERPENE MIXURE (ROWATINEX¢Ç)
- Failure of rumalon to increase sulfate incorporation by articular chondrocytes in monolayer culture
- Rumalon and serum-free culture of chondrocytes
- Treatment of osteoarthritis with rumalon R
- Amelioration of lapine osteoarthritis by treatment with glycosaminoglycan–peptide association complex (Rumalon)
- Ultrastructural and morphometrical studies on the articular cartilage of rats: the destructive effect of Dexamethasone and the chondroprotective effect of RUMALON®
- The mode of action of a glycosaminoglycan-peptide-complex (Rumalon®) on articular cartilage of the rat in vivo
- Attempts in vivo to mimic Rumalon's (R) action in OA cartilage in the Pond-Nuki canine model
- A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon®) as a structure modifying therapy in osteoarthritis of the hip and knee
- A single-blind, placebo-controlled study of glycosaminoglycan-peptide complex ('Rumalon') in patients with osteoarthritis of the hip or knee
Customers who bought this product also bought:
8 other products in the same category:
arrow_upward